CohBar Inc Stock
CohBar Inc Stock price
Key metrics
| Market capitalization | $1.60m |
| Enterprise Value | $-10.71m |
| EV/FCF (TTM) EV/FCF | 1.35 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-13.13m |
| Free Cash Flow (TTM) Free Cash Flow | $-7.95m |
| Cash position | $12.31m |
| EPS (TTM) EPS | $-4.37 |
| Short interest | 0.52% |
Is CohBar Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
CohBar Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast CohBar Inc:
Analyst Opinions
1 Analyst has issued a forecast CohBar Inc:
Financial data from CohBar Inc
| Jun '23 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.10 -0.10 |
23%
23%
|
|
| EBITDA | -13 -13 |
8%
8%
|
EBIT (Operating Income) EBIT | -13 -13 |
8%
8%
|
| Net Profit | -13 -13 |
4%
4%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about CohBar Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.
| Head office | United States |
| CEO | Joseph Sarret |
| Founded | 2007 |
| Website | www.cohbar.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
